Compounds and uses thereof in modulating amyloid beta

Details for Australian Patent Application No. 2004247013 (hide)

Owner Neurogenetic Pharmaceuticals, Inc.

Inventors Mao, Long; Comer, Daniel D.; Balow, Guity P.; Cheng, Soan; Pleynet, David

Agent Spruson & Ferguson

Pub. Number AU-B-2004247013

PCT Pub. Number WO2004/110350

Priority 60/470,884 14.05.03 US; 60/532,260 22.12.03 US

Filing date 14 May 2004

Wipo publication date 23 December 2004

Acceptance publication date 8 July 2010

International Classifications

C07D 417/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/425 (2006.01) - Thiazoles

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

C07D 277/04 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/42 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 413/00 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/110350 Priority application(s): WO2004/110350

15 October 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Compounds and uses thereof in modulating amyloid beta

1 July 2010 Assignment before Grant

  Torreypines Therapeutics, Inc. The application has been assigned to Neurogenetic Pharmaceuticals, Inc. 2005

8 July 2010 Application Accepted

  Published as AU-B-2004247013

4 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247015-Drug conjugate composition

2004247012-Targeted biocides